TENDER OFFER AGREEMENT BETWEEN TXCELL S.A. AND SANGAMO THERAPEUTICS, INC. Dated as of July 20, 2018Tender Offer Agreement • July 23rd, 2018 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
NOW, THEREFORE, in consideration of the foregoing and the mutual representations, warranties, covenants and agreements set forth herein, the Parties agree as follows:
SHARE PURCHASE AGREEMENTShare Purchase Agreement • July 23rd, 2018 • Sangamo Therapeutics, Inc • Biological products, (no disgnostic substances)
This share purchase agreement (this “Agreement”), dated as of July 20, 2018, is entered into by and among (i) Sangamo Therapeutics, Inc., a company incorporated in the State of Delaware, whose head office is located at 501 Canal Blvd, Richmond, CA 94804, U.S.A. (the “Purchaser”) and (ii) the persons listed in Exhibit A (hereafter collectively referred to as the “Sellers” and individually as a “Seller”).
